New Delhi: Piramal Pharma on Tuesday said it has invested Rs 101.77 crore in Hyderabad-based Yapan Bio to augment the capabilities of its contract development and manufacturing organisation (CDMO) business. The Mumbai-based company has acquired a 27.78 per cent stake in Yapan as a result of the investment. The investment will allow Piramal Pharma to […]
